← Leaderboards
Michael J Mahan
University Of California Santa Barbara
$6,401,613
Attributed
$6,401,613
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $765.2K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,401,613 · 4
By mechanism
P01$4,448,345 · 2
R01$1,374,147 · 1
R21$579,121 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Santa Barbara
Same institution · by research overlap
- David Alan Low$5,093,302
- John J. Perona$6,641,193
Others in their field
Top investigators on “Salmonella Typhimurium”
- Jorge E Galan · Yale University$27,917,656
- Andreas J Baumler · Texas A&M University Health Science Ctr$21,644,776
- Ferric C Fang · University Of Washington$20,288,270
- Roy Curtiss · Washington University$20,061,438
- Ramnik J Xavier · Broad Institute, Inc.$14,140,132
- Denise M. Monack · Stanford University$14,023,917
Research focus
Salmonella TyphimuriumVirulenceMicrobialImmune ResponsePathogenSalmonellaInfectionVirulentEscherichia ColiPathogenesisProtein GlycosylationProgramsCore FacilityCoagulation ProcessReceptorBlood Coagulation FactorAffectInflammationMortalityBlood Coagulation DisordersHematologyBloodPlasmaGlycoproteins
Grant awards (15)
PROJECT 2 - Mechanisms of Hypervirulence in the Pathogenesis of Sepsis$451,230
P01 · FY2025 · HL · contact PI
PROJECT 2 - Mechanisms of Hypervirulence in the Pathogenesis of Sepsis$443,655
P01 · FY2024 · HL · contact PI
PROJECT 2 - Mechanisms of Hypervirulence in the Pathogenesis of Sepsis$451,303
P01 · FY2023 · HL · contact PI
PROJECT 2 - Mechanisms of Hypervirulence in the Pathogenesis of Sepsis$451,308
P01 · FY2022 · HL · contact PI
PROJECT 2 - Mechanisms of Hypervirulence in the Pathogenesis of Sepsis$460,733
P01 · FY2021 · HL · contact PI
Project 2: Host-Pathogen Interactions in Blood Glycoprotein Modulation of Sepsis$434,357
P01 · FY2020 · HL · contact PI
Project 2: Host-Pathogen Interactions in Blood Glycoprotein Modulation of Sepsis$434,357
P01 · FY2019 · HL · contact PI
Project 2: Host-Pathogen Interactions in Blood Glycoprotein Modulation of Sepsis$434,357
P01 · FY2018 · HL · contact PI
Project 2: Host-Pathogen Interactions in Blood Glycoprotein Modulation of Sepsis$434,783
P01 · FY2017 · HL · contact PI
Project 2: Host-Pathogen Interactions in Blood Glycoprotein Modulation of Sepsis$452,262
P01 · FY2016 · HL · contact PI
Cross-Protective Vaccines Against Emerging Infectious Agents$442,739
R01 · FY2007 · AI · contact PI
Cross-Protective Vaccines vs. Emerging Infectious Agents$456,375
R01 · FY2006 · AI · contact PI
Cross-Protective Vaccines vs. Emerging Infectious Agents$475,033
R01 · FY2005 · AI
Epigenetic Control of Bacterial Virulence$290,196
R21 · FY2005 · AI
Epigenetic Control of Bacterial Virulence$288,925
R21 · FY2004 · AI